Formulary Management for Gastrointestinal-2 (GI-2) Miscellaneous Drugs
The Director, DHA, approved the recommendations from the November 2015 DoD P&T Committee meeting on January 29, 2016.
This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil View the external links disclaimer.